Is there a basis for distinguishing two types of P2-purinoceptor?

No abstract is available for this paper.

• Publication year

  1985

• Venue

  General Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0306-3623(85)90001-1PMID 2996968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies on the stereoselectivity of the P2‐purinoceptor on the guinea‐pig vas deferens

  1985cited by this paper
• ATP produces vasodilation via P1 purinoceptors and vasoconstriction via P2 purinoceptors in the isolated rabbit central ear artery.

  1985cited by this paper
• Specificity of P2-purinoceptor that mediates endothelium-dependent relaxation of the pig aorta.

  1985cited by this paper
• Evidence for two types of P2-purinoceptor in longitudinal muscle of the rabbit portal vein.

  1985cited by this paper
• P2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery.

  1985cited by this paper
• Effects of phosphorothioate analogues of ATP, ADP and AMP on guinea‐pig taenia coli and urinary bladder

  1984cited by this paper
• Evidence for an inhibitory prejunctional P1-purinoceptor in the rat portal vein with characteristics of the A2 rather than of the A1 subtype.

  1984cited by this paper
• Inhibition of excitatory junction potentials in guinea-pig vas deferens by alpha, beta-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters.

  1984cited by this paper
• Inhibition of excitatory junction potentials in guinea-pig vas deferens by α, β-methylene-ATP: Further evidence for ATP and noradrenaline as cotransmitters

  1984cited by this paper
• A study of the atropine-resistant component of the neurogenic response of the rabbit urinary bladder.

  1984cited by this paper
• ATP as a co-transmitter in rat tail artery.

  1984cited by this paper
• Studies on the stereoselectivity of the P2‐purinoceptor

  1983cited by this paper
• Blockade of non-cholinergic non-adrenergic colonic contraction in response to pelvic nerve stimulation by large doses of alpha, beta-methylene ATP.

  1983cited by this paper
• Evidence for purinergic receptors on vascular smooth muscle in rat pancreas.

  1983cited by this paper
• Evidence for a contribution by purines to the neurogenic response of the guinea-pig urinary bladder.

  1983cited by this paper
• Different effector mechanisms for ATP and adenosine hyperpolarization in the guinea-pig taenia coli.

  1983cited by this paper
• Evidence that ATP acts as a co-transmitter with noradrenaline in sympathetic nerves supplying the guinea-pig vas deferens.

  1983cited by this paper
• Blockade of non‐cholinergic non‐adrenergic colonic contraction in response to pelvic nerve stimulation by large doses of α, β‐methylene ATP

  1983cited by this paper
• Effects of desensitization to adenosine 5‘‐triphosphate and vasoactive intestinal polypeptide on non‐adrenergic inhibitory responses of longitudinal and circular muscles in the rat ileum

  1983cited by this paper
• Stereoselectivity of ectonucleotidases on vascular endothelial cells.

  1983cited by this paper
• Pharmacological characterization of purinergic receptors in the rat vas deferens.

  1983cited by this paper
• The effect of adenyl compounds on the rat heart

  1983cited by this paper
• Mechanism of photoaffinity labeling of P2-purinergic receptors by arylazido aminopropionyl atp in isolated guinea-pig vas deferens.

  1982cited by this paper
• Comparison of the effects of arylazido aminopropionyl ATP (ANAPP3), an ATP antagonist, on responses of the smooth muscle of the guinea-pig vas deferens to ATP and related nucleotides.

  1982cited by this paper
• The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder.

  1982cited by this paper
• Effect of arylazido aminopropionyl ATP (ANAPP3), on ATP responses of isolated guinea pig smooth muscle.

  1982cited by this paper
• Cotransmitters in the motor nerves of the guinea pig vas deferens: electrophysiological evidence.

  1982cited by this paper
• Mode of action of ATP on propulsive activity in rabbit colon.

  1982cited by this paper
• Evidence for a prostaglandin link in the purinergic activation of rabbit bladder smooth muscle.

  1982cited by this paper
• Investigation of relaxations of the rabbit anococcygeus muscle by nerve stimulation and ATP using the ATP antagonist ANAPP3.

  1982cited by this paper
• Evidence for the presence of P1-purinoceptors on cholinergic nerve terminals in the guinea-pig ileum.

  1982cited by this paper
• Comparison of contractions of the smooth muscle of the guinea-pig vas deferens induced by ATP and related nucleotides.

  1982cited by this paper
• Direct evidence against a role of ATP as the nonadrenergic, noncholinergic inhibitory neurotransmitter in guinea pig tenia coli.

  1982cited by this paper
• Noradrenergic neuromuscular transmission with special reference to arterial smooth muscle.

  1982cited by this paper
• EFFECTS OF DESENSITIZATION TO ADENOSINE 5′‐TRIPHOSPHATE AND ADENOSINE ON NON‐ADRENERGIC INHIBITORY RESPONSES IN THE CIRCULAR MUSCLE OF RABBIT COLON

  1982cited by this paper
• Evidence for separate receptors for ATP and adenosine in the guinea-pig taenia coli.

  1982cited by this paper
• Effect of arylazido aminopropionyl ATP (ANAPP3), a putative ATP antagonist, on ATP responses of isolated guinea pig smooth muscle

  1982cited by this paper
• The co-transmitter hypothesis, with special reference to the storage and release of ATP with noradrenaline and acetylcholine

  1982cited by this paper
• EVIDENCE IN SUPPORT OF THE P1/P2 PURINOCEPTOR HYPOTHESIS IN THE GUINEA‐PIG TAENIA COLI

  1981cited by this paper
• Contribution by purines to the neurogenic response of the vas deferens of the guinea pig.

  1981cited by this paper
• Purinergic Receptors in Blood Vessels

  1981cited by this paper
• The effects of nucleotides on the response of the isolated guinea pig urinary bladder to nonadrenergic, noncholinergic nerve stimulation.

  1981cited by this paper
• Non‐adrenergic inhibition of the longitudinal muscle of rabbit distal colon may not be mediated by purinergic nerves

  1981cited by this paper
• ATP, beta-gamma-methylene-ATP, and adenosine inhibit non-cholinergic non-adrenergic transmission in rat urinary bladder.

  1980cited by this paper
• ATP, β-γ-methylene-ATP, and adenosine inhibit non-cholinergic non-adrenergic transmission in rat urinary bladder

  1980cited by this paper
• Subclasses of external adenosine receptors.

  1980cited by this paper
• Purinergic receptors: photoaffinity analog of adenosine triphosphate is a specific adenosine triphosphate antagonist.

  1980cited by this paper
• The action of apamin on guinea-pig taenia caeci.

  1980cited by this paper
• Effect of apamin on the electrical responses of smooth muscle to adenosine 5'-triphosphate and to non-adrenergic, non-cholinergic nerve stimulation.

  1980cited by this paper
• Evidence for two adenine derivative receptors in rat ileum which are not involved in the nonadrenergic, noncholinergic response.

  1979cited by this paper
• Effects of adenosine 5'-triphosphate (ATP) and beta-gamma-methylene ATP on the rat urinary bladder.

  1979cited by this paper
• ADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLS

  1979cited by this paper
• EFFECTS OF ADENOSINE 5′‐TRIPHOSPHATE (ATP) AND β‐γ‐METHYLENE ATP ON THE RAT URINARY BLADDER

  1979cited by this paper
• The contribution of adenosine to the inhibitory actions of adenine nucleotides on the guinea-pig taenia coli: studies with phosphate-modified adenine nucleotide analogs and dipyridamole.

  1979cited by this paper
• RELAXATION OF ISOLATED TAENIA COLI OF GUINEA‐PIG BY ENANTIOMERS OF 2‐AZIDO ANALOGUES OF ADENOSINE AND ADENINE NUCLEOTIDES

  1979cited by this paper
• Apamin blocks certain neurotransmitter-induced increases in potassium permeability

  1979cited by this paper
• The effect of apamin on the smooth muscle cells of the guinea-pig taenia coli.

  1979cited by this paper
• A basis for distinguishing two types of purinergic receptor

  1978cited by this paper
• Contribution of adrenergic and "purinergic" neurotransmission to contraction in rabbit detrusor.

  1978cited by this paper
• COMPARISON OF THE EFFECTS OF ULTRAVIOLET LIGHT AND PURINERGIC NERVE STIMULATION ON THE GUINEA‐PIG TAENIA COLI

  1978cited by this paper
• PURINERGIC INNERVATION OF THE GUINEA‐PIG URINARY BLADDER

  1978cited by this paper
• Do some nerve cells release more than one transmitter?

  1976cited by this paper
• Ion fluxes during the inhibitory junction potential in the guinea‐pig taenia coli.

  1975cited by this paper
• Inhibitory effects of adenine nucleotide analogs on the isolated guinea-pig taenia coli.

  1975cited by this paper
• A comparison of the effects of adenosine triphosphate with noradrenaline and with the inhibitory potential of the guinea‐pig taenia coli

  1973cited by this paper
• Three new adenosine triphosphate analogs. Synthesis and effects on isolated gut.

  1973cited by this paper
• Conductance change during the inhibitory potential in the guinea‐pig taenia coli

  1972cited by this paper
• Purinergic nerves.

  1972cited by this paper
• Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non‐adrenergic inhibitory nerves in the gut

  1970cited by this paper
• Further observations on ATP-induced histamine release from rat mast cells.

  1970cited by this paper
• Non‐cholinergic transmission by post‐ganglionic motor neurones in the mammalian bladder

  1970cited by this paper
• Relaxation of Mammalian Smooth Muscles by Visible and Ultraviolet Radiation

  1968cited by this paper
• Histamine release from isolated rat peritoneal mast cells induced by adenosine-5'-triphosphate.

  1967cited by this paper
• REGULATION OF CORONARY BLOOD FLOW.

  1964cited by this paper
• The Photoactivated Relaxation of Smooth Muscle of Rabbit Aorta

  1961cited by this paper
• The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart 1

  1929cited by this paper

• Autism Spectrum Disorders and Purinergic Signaling: A Systematic Review of Emerging Insights from Preclinical Studies

  2026cites this paper
• P2Y14 receptor in the nervous system: Pharmacology, mechanisms, and therapeutic potential.

  2026cites this paper
• Lipid Metabolism Alterations in Hereditary Inorganic Pyrophosphate Deficiency Syndromes: A Narrative Review of Insights and Controversies

  2025cites this paper
• Enhancing Remyelination by Blockade of Astrocytic P2X1 Receptors Signaling in Cuprizone‐Induced Demyelination Mouse Model

  2025cites this paper
• Design, Synthesis and Anti-Inflammatory Evaluation of 3-Substituted 5-Amidobenzoate Derivatives as Novel P2Y14 Receptor Antagonists via Structure-Guided Molecular Hybridization.

  2025cites this paper
• G protein-coupled purinergic P2Y receptors in infectious diseases.

  2025cites this paper
• Enteric glia and purinergic signaling in health and disease.

  2025cites this paper
• P2 purinergic signaling and pruritus.

  2025cites this paper
• The Role of Purine Metabolism and Uric Acid in Postnatal Neurologic Development

  2025cites this paper
• Discovery of a potent and in vivo anti-inflammatory Efficacious, P2Y14R antagonist with a novel benzisoxazoles scaffold by DNA-encoded chemical library technology.

  2025cites this paper
• Astrocytic Receptor Systems of the Basal Ganglia

  2025cites this paper
• Nitric oxide modulates UDP-evoked cytosolic transients via P2Y6 purinoceptor stimulation

  2025cites this paper
• A Bibliometric Analysis of P2X7R in Cardiovascular Diseases From 2005 to 2024.

  2025cites this paper
• The progress and prospects of targeting the adenosine pathway in cancer immunotherapy

  2025cites this paper
• Molecular Docking Analysis Of P2x Receptor Antagonists: Insights Into Neurological Pain Modulation

  2025cites this paper
• The P2X3 receptor blocker AF-353 (Ro-4) reduces bioenergetic index of a primary mixed culture of hippocampal neurons.

  2025cites this paper
• The Multifaceted Role of P2X7R in Microglia and Astrocytes

  2025cites this paper
• Subtype-specific structural features of the hearing loss–associated human P2X2 receptor

  2025cites this paper
• Purinergic System Transcript Changes in the Dorsolateral Prefrontal Cortex in Suicide and Major Depressive Disorder

  2025cites this paper
• Exploring P2X receptor activity: A journey from cellular impact to electrophysiological profiling.

  2024cites this paper
• Overview of the role of purinergic signaling and insights into its role in cancer therapy.

  2024cites this paper
• Interstitial Cells of Cajal and P2X3 Receptors at Ureteropelvic Junction Obstruction and Their Relationship with Pain Response

  2024cites this paper
• Sex differences in the purinergic 2 receptor mediated blood pressure response to treadmill exercise in rats with simulated peripheral artery disease.

  2024cites this paper
• Extracellular ATP is a homeostatic messenger that mediates cell‒cell communication in physiological processes and psychiatric diseases.

  2024cites this paper
• Discovery of a potent, Highly selective, and In vivo anti-inflammatory Efficacious, P2Y6R antagonist with a novel quinoline-pyrazole scaffold.

  2024cites this paper
• Implications of COVID-19 in Parkinson’s disease: the purinergic system in a therapeutic-target perspective to diminish neurodegeneration

  2024cites this paper
• Does Adenosine Triphosphate via Purinergic Receptor Signalling Fuel Pulmonary Fibrosis?

  2024cites this paper
• Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human

  2024cites this paper
• Mechanosensitive release of ATP in the urinary bladder mucosa

  2024cites this paper
• Pharmacological characterization of P2Y receptor subtypes – an update

  2023cites this paper
• Role of ATP in migraine mechanisms: focus on P2X3 receptors

  2023cites this paper
• Purinergic Signaling and its Role in the Stem Cell Differentiation.

  2023cites this paper
• Systematic P2Y receptor survey identifies P2Y11 as modulator of immune responses and virus replication in macrophages

  2023cites this paper
• Purinergic receptors in cognitive disturbances.

  2023cites this paper
• The Neuronal Cotransmission: Mechanistic Insights From the Autonomic Nervous System

  2023cites this paper
• Melatonin attenuated chronic visceral pain by reducing Nav1.8 expression and nociceptive neuronal sensitization

  2023cites this paper
• Purinergic signaling: Diverse effects and therapeutic potential in cancer

  2023cites this paper
• Channel-mediated ATP release in the nervous system.

  2023cites this paper
• P2X7 purinergic receptor: A potential target in heart diseases (Review).

  2023cites this paper
• Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists.

  2023cites this paper
• Diet, herbs and erectile function: A good friendship!

  2022cites this paper
• P2X receptors: Insights from the study of the domestic dog.

  2022cites this paper
• The purinergic signalling and inflammation in the pathogenesis and progression of diabetes: key factors and therapeutic targets

  2022cites this paper
• Extracellular Vesicle-Mediated Metastasis Suppressors NME1 and NME2 Modify Lipid Metabolism in Fibroblasts

  2022cites this paper
• High P2X6 receptor expression in human bladder cancer predicts good survival prognosis

  2022cites this paper
• More than a drug target: Purinergic signalling as a source for diagnostic tools in epilepsy.

  2022cites this paper
• The circadian regulation of extracellular ATP

  2022cites this paper
• Purinergic signaling in the male reproductive tract

  2022cites this paper
• P2X7-dependent immune pathways in retinal diseases.

  2022cites this paper
• P2X and P2Y receptor antagonists reduce inflammation in ATP-induced microglia

  2022cites this paper
• Dietary and nutraceutical-based therapeutic approaches to combat the pathogenesis of Huntington’s disease

  2022cites this paper
• Overview for the study of P2 receptors: From P2 receptor history to neuropathic pain studies.

  2022cites this paper
• Recent progress in the structural biology of P2X receptors

  2022cites this paper
• Enlightening activation gating in P2X receptors

  2022cites this paper
• Second meeting of the Australian and New Zealand Purine Club

  2022cites this paper
• P2Y Receptors in Bone - Anabolic, Catabolic, or Both?

  2022cites this paper
• Discovery of a Series of 5-Amide-1H-pyrazole-3-carboxyl Derivatives as Potent P2Y14R Antagonists with Anti-Inflammatory Characters.

  2022cites this paper
• Treatment of chronic cough: P2X3 receptor antagonists and beyond.

  2022cites this paper
• Geoffrey Burnstock. 10 May 1929—3 June 2020

  2021cites this paper
• Analysis of Spatial and Temporal Distribution of Purinergic P2 Receptors in the Mouse Hippocampus

  2021cites this paper
• Biological insights from the direct measurement of purine release.

  2021cites this paper
• Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue

  2021cites this paper
• The discovery and development of gefapixant.

  2021cites this paper
• Purinergic signalling in the urinary bladder - When function becomes dysfunction.

  2021cites this paper
• The P2Y/P2X divide: how it began.

  2021cites this paper
• ATP as a cotransmitter in sympathetic and parasympathetic nerves - another Burnstock legacy.

  2021cites this paper
• Effects of a P2X7 receptor antagonist on myenteric neurons in the distal colon of an experimental rat model of ulcerative colitis

  2021cites this paper
• Structural basis for the functional properties of the P2X7 receptor for extracellular ATP

  2021cites this paper
• Health and ergogenic potential of oral adenosine-5′-triphosphate (ATP) supplementation

  2021cites this paper
• Isolation of Arabidopsis extracellular ATP-binding proteins by affinity proteomics and identification of PHOSPHOLIPASE C-LIKE 1 as an extracellular protein essential for fumonisin B1 toxicity.

  2021cites this paper
• Role of TRPV4-P2X7 Pathway in Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion

  2021cites this paper
• Neurotransmitters responsible for purinergic motor neurotransmission and regulation of GI motility.

  2021cites this paper
• Purinergic Regulation of Endothelial Barrier Function

  2021cites this paper
• Reduction of prefrontal purinergic signaling is necessary for the analgesic effect of morphine

  2021cites this paper
• The role of P2Y receptors in regulating immunity and metabolism.

  2021cites this paper
• P2X3 receptors participate in purinergic inhibition of gastrointestinal smooth muscle.

  2021cites this paper
• [A Review of the State of Purinergic Signaling and Psychological Stress].

  2021cites this paper
• Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer

  2021cites this paper
• Chronic cough: new insights and future prospects

  2021cites this paper
• Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor

  2021cites this paper
• That was then, this is now: the development of our knowledge and understanding of P2 receptor subtypes

  2021cites this paper
• Molecular Modeling Applied to the Discovery of New Lead Compounds for P2 Receptors Based on Natural Sources

  2020cites this paper
• The Role of Purinergic Signaling in Trichomonas vaginalis Infection.

  2020cites this paper
• P2X7 receptor and the NLRP3 inflammasome: partners in crime.

  2020cites this paper
• Purinergic receptors in airway hydration.

  2020cites this paper
• The FGF2‐induced tanycyte proliferation involves a connexin 43 hemichannel/purinergic‐dependent pathway

  2020cites this paper
• P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases

  2020cites this paper
• Plant natural products as source of new P2 receptors ligands.

  2020cites this paper
• Obituary Geoff Burnstock (1929–2020)

  2020cites this paper
• P2 Purinergic Signaling in the Distal Lung in Health and Disease

  2020cites this paper
• Adenosine metabolism in the vascular system.

  2020cites this paper
• Functional studies of purinergic and cholinergic interactions in the rat urinary bladder - Characterization of ATP-evoked urothelial release of acetylcholine

  2020influential citation
• Geoffrey Burnstock, our friend and magister: the diadenosine polyphosphate connection

  2020cites this paper
• Molecular Pharmacology of P2Y Receptor Subtypes.

  2020cites this paper
• The Role of Purinergic Receptors in the Circadian System

  2020cites this paper
• Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases

  2020cites this paper
• New small molecule fluorescent probes for G protein-coupled receptors: valuable tools for drug discovery.

  2020cites this paper
• Tribute to Prof. Geoffrey Burnstock: transition of purinergicsignaling to drug discovery

  2020cites this paper
• Alzheimer’s Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease

  2020cites this paper
• Conservation of eATP perception throughout multicellular animal evolution: Identification and functional characterization of coral and amphioxus P2X7-like receptors and flounder P2X7 receptor.

  2020cites this paper